2019
DOI: 10.1111/1346-8138.14875
|View full text |Cite
|
Sign up to set email alerts
|

Hearing loss caused by discoid lupus erythematosus of the ear canal successfully treated with hydroxychloroquine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
4
0
1

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 4 publications
0
4
0
1
Order By: Relevance
“…In these patients, the mechanism is mostly of conductive type, probably related to the presence of DLE lesions within the ear canal. 5 Treatment by steroids, hydroxychloroquine, and/or immunosuppressive drugs improves not only the cutaneous manifestations but also both the sensorineural and conductive hearing loss. 4 A clinical presentation similar to that observed in our patient has been reported also under the term of comedonal or comedogenic lupus erythematosus (LE).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…In these patients, the mechanism is mostly of conductive type, probably related to the presence of DLE lesions within the ear canal. 5 Treatment by steroids, hydroxychloroquine, and/or immunosuppressive drugs improves not only the cutaneous manifestations but also both the sensorineural and conductive hearing loss. 4 A clinical presentation similar to that observed in our patient has been reported also under the term of comedonal or comedogenic lupus erythematosus (LE).…”
Section: Discussionmentioning
confidence: 99%
“…4,5 The mechanism of inner ear damage remains unclear, but could be related to microinfarctions after thrombosis in the inner ear. 5 The exact frequency of hearing loss in patients with DLE is not known. In these patients, the mechanism is mostly of conductive type, probably related to the presence of DLE lesions within the ear canal.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Esta medicação foi a utilizada por 65,7% dos sujeitos com LES do estudo analisado, fazendo parte do tratamento de 80% dos pacientes com perda auditiva. Esta droga também foi utilizada em larga escala no tratamento de pacientes com LES em outros estudos compilados na literatura [32][33][34] .…”
Section: Forma De Seleção Dos Estudosunclassified